Cross-neutralization potential of native human papillomavirus N-terminal L2 epitopes.
about
The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infectionDifferentiation-dependent interpentameric disulfide bond stabilizes native human papillomavirus type 16Differential dependence on host cell glycosaminoglycans for infection of epithelial cells by high-risk HPV typesA vaccine of L2 epitope repeats fused with a modified IgG1 Fc induced cross-neutralizing antibodies and protective immunity against divergent human papillomavirus types.Inhibition of Langerhans cell maturation by human papillomavirus type 16: a novel role for the annexin A2 heterotetramer in immune suppression.Roles for human papillomavirus type 16 l1 cysteine residues 161, 229, and 379 in genome encapsidation and capsid stabilityHuman papillomavirus type 18 chimeras containing the L2/L1 capsid genes from evolutionarily diverse papillomavirus types generate infectious virus.Second-generation prophylactic HPV vaccines: successes and challenges.Comparisons of VLP-Based ELISA, Neutralization Assays with Native HPV, and Neutralization Assays with PsV in Detecting HPV Antibody Responses in HIV-Infected WomenLaboratory and clinical aspects of human papillomavirus testingCleavage of the HPV16 Minor Capsid Protein L2 during Virion Morphogenesis Ablates the Requirement for Cellular Furin during De Novo Infection.Phylogenetic considerations in designing a broadly protective multimeric L2 vaccinePreparation and properties of a papillomavirus infectious intermediate and its utility for neutralization studies.HPV entry into cells.Natural variants in the major neutralizing epitope of human papillomavirus minor capsid protein L2.Mutations in HPV18 E1^E4 Impact Virus Capsid Assembly, Infectivity Competence, and Maturation.Antibody Competition Reveals Surface Location of HPV L2 Minor Capsid Protein Residues 17-36.The human papillomavirus E6 oncoprotein targets USP15 and TRIM25 to suppress RIG-I-mediated innate immune signaling.Superinfection Exclusion between Two High-Risk Human Papillomavirus (HPV) Types During a Co-Infection.Displaying 31RG-1 peptide on the surface of HPV16 L1 by use of a human papillomavirus chimeric virus-like particle induces cross-neutralizing antibody responses in mice.Enantioselective Inhibition of Human Papillomavirus L1 Pentamer Formation by Chiral-Proline Modified Calix[4]arenes: Targeting the Protein Interface
P2860
Q21134079-004C199B-237D-4060-A786-841CDE415523Q28479209-57AB378B-0DDC-402D-8B72-0F809DEA1997Q28534531-82799DE8-9153-476D-B665-2AFE43B2398AQ33572691-6AAC479B-5711-4ABF-BDCE-8C95D6CD0ACDQ33604135-D3A266D8-D32C-4F49-8729-FA43C08DA377Q33740579-A9F7D3FB-9A0E-4CA4-BF78-87C4C08416B5Q35186597-788311F0-9626-467F-A00A-582DFF19ACFDQ35541886-34B51AA4-E6E1-41C1-8B05-AA5AF2FAA2EEQ35743769-9A1CF633-26A0-4106-B906-62EFF46A152EQ36311573-55BDED13-E0D0-4914-A101-F133EBB87164Q36333638-AEB8BE3E-4C06-425F-BD1D-06DF155B216CQ36827128-DCA61AF0-0FF3-497C-B37B-822B57755E75Q37599123-E5642894-74A2-424A-A4DF-B0DFACECF089Q39320596-3A49FBE6-A01B-40AB-96CE-166594130C8CQ45338163-D4D4528F-4D2A-4A77-85E2-1363F13D8901Q47108460-2ACEFB9D-1689-4056-99F7-4C7A578DC95FQ47143249-FCCCB272-E7D3-4EEE-9BA8-19AB41D6A09AQ47562558-EAA5BF05-9995-4921-80D2-DB5F6FB939F5Q50043357-A1710E34-6417-47EF-9994-A2300663EBF3Q52312756-9D454765-E7FA-4D1A-A1CC-42FA64478053Q58450632-677D388F-1F52-4371-AA2C-35A3D17A0244
P2860
Cross-neutralization potential of native human papillomavirus N-terminal L2 epitopes.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cross-neutralization potential of native human papillomavirus N-terminal L2 epitopes.
@ast
Cross-neutralization potential of native human papillomavirus N-terminal L2 epitopes.
@en
type
label
Cross-neutralization potential of native human papillomavirus N-terminal L2 epitopes.
@ast
Cross-neutralization potential of native human papillomavirus N-terminal L2 epitopes.
@en
prefLabel
Cross-neutralization potential of native human papillomavirus N-terminal L2 epitopes.
@ast
Cross-neutralization potential of native human papillomavirus N-terminal L2 epitopes.
@en
P2093
P2860
P1433
P1476
Cross-neutralization potential of native human papillomavirus N-terminal L2 epitopes.
@en
P2093
Craig Meyers
Linda Cruz
Michael J Conway
Neil David Christensen
Samina Alam
P2860
P304
P356
10.1371/JOURNAL.PONE.0016405
P407
P577
2011-02-08T00:00:00Z